Maija Parkkonen

1.6k total citations
21 papers, 661 citations indexed

About

Maija Parkkonen is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Genetics. According to data from OpenAlex, Maija Parkkonen has authored 21 papers receiving a total of 661 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Endocrinology, Diabetes and Metabolism, 8 papers in Molecular Biology and 6 papers in Genetics. Recurrent topics in Maija Parkkonen's work include Diabetes and associated disorders (5 papers), Metabolomics and Mass Spectrometry Studies (4 papers) and Liver Disease Diagnosis and Treatment (3 papers). Maija Parkkonen is often cited by papers focused on Diabetes and associated disorders (5 papers), Metabolomics and Mass Spectrometry Studies (4 papers) and Liver Disease Diagnosis and Treatment (3 papers). Maija Parkkonen collaborates with scholars based in Finland, Australia and United States. Maija Parkkonen's co-authors include Per‐Henrik Groop, Carol Forsblom, Ville‐Petteri Mäkinen, Kimmo Kaski, Mika Ala‐Korpela, Pasi Soininen, Petri Ingman, Maija Wessman, Johan Wadén and Kustaa Hietala and has published in prestigious journals such as PLoS ONE, Diabetes Care and Diabetes.

In The Last Decade

Maija Parkkonen

21 papers receiving 645 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Maija Parkkonen Finland 13 264 212 200 116 103 21 661
Adán Valladares‐Salgado Mexico 16 222 0.8× 163 0.8× 164 0.8× 89 0.8× 66 0.6× 50 717
Fuki Ikeda Japan 15 249 0.9× 284 1.3× 124 0.6× 216 1.9× 227 2.2× 38 753
Marlena Maziarz United States 15 315 1.2× 319 1.5× 184 0.9× 316 2.7× 61 0.6× 41 869
Masaaki Eto Japan 14 167 0.6× 284 1.3× 61 0.3× 239 2.1× 138 1.3× 49 713
Sarju Ralhan India 17 271 1.0× 201 0.9× 366 1.8× 159 1.4× 142 1.4× 31 833
Rena Pollack Israel 13 159 0.6× 278 1.3× 67 0.3× 89 0.8× 57 0.6× 32 676
Shao Zhong China 13 165 0.6× 182 0.9× 50 0.3× 76 0.7× 63 0.6× 56 633
Hiroaki Akai Japan 16 328 1.2× 160 0.8× 57 0.3× 127 1.1× 65 0.6× 32 754
Fuu‐Jen Tsai Taiwan 16 295 1.1× 62 0.3× 92 0.5× 86 0.7× 53 0.5× 52 693
M. Rathaus Israel 13 370 1.4× 136 0.6× 62 0.3× 71 0.6× 82 0.8× 56 951

Countries citing papers authored by Maija Parkkonen

Since Specialization
Citations

This map shows the geographic impact of Maija Parkkonen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maija Parkkonen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maija Parkkonen more than expected).

Fields of papers citing papers by Maija Parkkonen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maija Parkkonen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maija Parkkonen. The network helps show where Maija Parkkonen may publish in the future.

Co-authorship network of co-authors of Maija Parkkonen

This figure shows the co-authorship network connecting the top 25 collaborators of Maija Parkkonen. A scholar is included among the top collaborators of Maija Parkkonen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maija Parkkonen. Maija Parkkonen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Guo, Jing, Owen J. L. Rackham, Niina Sandholm, et al.. (2020). Whole-Genome Sequencing of Finnish Type 1 Diabetic Siblings Discordant for Kidney Disease Reveals DNA Variants associated with Diabetic Nephropathy. Journal of the American Society of Nephrology. 31(2). 309–323. 13 indexed citations
2.
Syreeni, Anna, Niina Sandholm, Jingjing Cao, et al.. (2019). Genetic Determinants of Glycated Hemoglobin in Type 1 Diabetes. Diabetes. 68(4). 858–867. 14 indexed citations
3.
Söderlund, Jenny, Carol Forsblom, Jorma Ilonen, et al.. (2012). HLA class II is a factor in cardiovascular morbidity and mortality rates in patients with type 1 diabetes. Diabetologia. 55(11). 2963–2969. 9 indexed citations
4.
Wessman, Maija, Carol Forsblom, Mari Kaunisto, et al.. (2011). Novel Susceptibility Locus at 22q11 for Diabetic Nephropathy in Type 1 Diabetes. PLoS ONE. 6(9). e24053–e24053. 10 indexed citations
5.
Möllsten, Anna, Nathalie Vionnet, Carol Forsblom, et al.. (2011). A polymorphism in the angiotensin II type 1 receptor gene has different effects on the risk of diabetic nephropathy in men and women. Molecular Genetics and Metabolism. 103(1). 66–70. 15 indexed citations
6.
Sallinen, Riitta, Jenny Söderlund, Carol Forsblom, et al.. (2010). DDOST, PRKCSH and LGALS3, which encode AGE-receptors 1, 2 and 3, respectively, are not associated with diabetic nephropathy in type 1 diabetes. Diabetologia. 53(9). 1903–1907. 9 indexed citations
7.
Mäkinen, Ville‐Petteri, Pasi Soininen, Carol Forsblom, et al.. (2008). 1 H NMR metabonomics approach to the disease continuum of diabetic complications and premature death. Molecular Systems Biology. 4(1). 167–167. 138 indexed citations
8.
Mäkinen, Ville‐Petteri, Carol Forsblom, Lena M. Thorn, et al.. (2008). Metabolic Phenotypes, Vascular Complications, and Premature Deaths in a Population of 4,197 Patients With Type 1 Diabetes. Diabetes. 57(9). 2480–2487. 73 indexed citations
9.
Gordin, Daniel, Carol Forsblom, Mats Rönnback, et al.. (2008). Acute hyperglycaemia induces an inflammatory response in young patients with type 1 diabetes. Annals of Medicine. 40(8). 627–633. 38 indexed citations
10.
Wadén, Johan, Lena M. Thorn, Carol Forsblom, et al.. (2007). Leisure-Time Physical Activity Is Associated With the Metabolic Syndrome in Type 1 Diabetes. Diabetes Care. 30(6). 1618–1620. 12 indexed citations
11.
Ihalmo, Pekka, Maija Wessman, Mari Kaunisto, et al.. (2007). Association analysis of podocyte slit diaphragm genes as candidates for diabetic nephropathy. Diabetologia. 51(1). 86–90. 16 indexed citations
12.
Turunen, Joni A., Maija Wessman, Carol Forsblom, et al.. (2006). Association analysis of the AIRE and insulin genes in Finnish type 1 diabetic patients. Immunogenetics. 58(5-6). 331–338. 34 indexed citations
13.
Mäkinen, Ville‐Petteri, Carol Forsblom, Maija Parkkonen, et al.. (2006). 1H NMR Metabonomics of Serum - Assessment of Molecular Indicators for Diabetic Nephropathy in Type 1 Diabetic Patients. 1 indexed citations
14.
Mäkinen, Ville‐Petteri, Pasi Soininen, Carol Forsblom, et al.. (2006). Diagnosing diabetic nephropathy by 1H NMR metabonomics of serum. Magnetic Resonance Materials in Physics Biology and Medicine. 19(6). 281–296. 57 indexed citations
15.
Bahr, Claudia, Sylvia Schön, Joachim Kühn, et al.. (2006). Novel sequence variants in the human xylosyltransferase I gene and their role in diabetic nephropathy. Diabetic Medicine. 23(6). 681–684. 4 indexed citations
16.
Mäkinen, Ville‐Petteri, Maija Parkkonen, Maija Wessman, et al.. (2005). High-throughput pedigree drawing. European Journal of Human Genetics. 13(8). 987–989. 35 indexed citations
17.
Stensland, Hilde Monica Frostad Riise, Janna Saarela, Maija Parkkonen, et al.. (2005). Fine mapping of the multiple sclerosis susceptibility locus on 5p14–p12. Journal of Neuroimmunology. 170(1-2). 122–133. 5 indexed citations
18.
Fröjdö, Sara, Maija Parkkonen, Ville‐Petteri Mäkinen, et al.. (2005). Polymorphisms in the gene encoding angiotensin I converting enzyme 2 and diabetic nephropathy. Diabetologia. 48(11). 2278–2281. 28 indexed citations
19.
Pajukanta, Päivi, Joseph D. Terwilliger, Markus Perola, et al.. (1999). Genomewide Scan for Familial Combined Hyperlipidemia Genes in Finnish Families, Suggesting Multiple Susceptibility Loci Influencing Triglyceride, Cholesterol, and Apolipoprotein B Levels. The American Journal of Human Genetics. 64(5). 1453–1463. 123 indexed citations
20.
Ekstrand, Agneta, Maija Parkkonen, A. Franssila-Kallunki, et al.. (1996). THE EFFECT OF (STEROID) IMMUNOSUPPRESSION ON SKELETAL MUSCLE GLYCOGEN METABOLISM IN PATIENTS AFTER KIDNEY TRANSPLANTATION. Transplantation. 61(6). 889–893. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Adán Valladares‐Salgado Breakdown of academic impact, for papers by Fuki Ikeda Breakdown of academic impact, for papers by Marlena Maziarz Breakdown of academic impact, for papers by Masaaki Eto Breakdown of academic impact, for papers by Sarju Ralhan Breakdown of academic impact, for papers by Rena Pollack Breakdown of academic impact, for papers by Shao Zhong Breakdown of academic impact, for papers by Hiroaki Akai Breakdown of academic impact, for papers by Fuu‐Jen Tsai Breakdown of academic impact, for papers by M. Rathaus
Rankless by CCL
2026